US Patent 10328087 Formulations for solubilizing hormones
Patent 10328087 was granted and assigned to TherapeuticsMD on June, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+97 characters)
Article
Patent abstract
Compositions and methods for the solubilization of steroid hormones are disclosed.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103280870
Date of Patent
June 25, 2019
0Patent Application Number
152173010
Date Filed
July 22, 2016
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Oct, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
103280870
Date of Patent
June 25, 2019
0Patent Application Number
152173010
Date Filed
July 22, 2016
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 27 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10328087 Formulations for solubilizing hormones
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10328087
Date of patent
June 25, 2019
Patent application number
15217301
Date Filed
July 22, 2016
Patent primary examiner
Find more entities like US Patent 10328087 Formulations for solubilizing hormones
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
